Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab

Total article views   Abstract views HTML views PDF downloads Totals
8,434 Dovepress* 5,824 1,232+ 1,284 7,056
PubMed Central* 0 1,378 462 1,378
Totals 5,824 2,610 1,746 8,434
*Since 22 August 2018
+Since July 2016

View citations on PubMed Central and Google Scholar